F113PS
COVIDIEN LTD
COVIDIEN LTD historical holders
total: 5
Greenlight Capital COVIDIEN LTD transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2014 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2015 Q1
David Einhorn has been an institutional investor in COVIDIEN LTD (F113PS) since 2014 Q4. According to 2026 Q1 report, David Einhorn doesn't hold any shares. The fund/company first acquired F113PS in 2014 Q4, initially purchasing 851,341 shares. Since the initial investment, Greenlight Capital has made 1 more transaction in this position.
When did David Einhorn exit their F113PS position?
David Einhorn no longer holds COVIDIEN LTD (F113PS). They sold off their entire position in 2015 Q1, closing out an investment that began in 2014 Q4.
When did David Einhorn first invest in F113PS?
David Einhorn first invested in COVIDIEN LTD (F113PS) in 2014 Q4 at the reported quarter-end price of $102.28 per share, acquiring 851,341 shares in their initial purchase.
What is David Einhorn's average cost basis for F113PS?
Based on historical transaction data, David Einhorn's estimated cost basis for COVIDIEN LTD (F113PS) is approximately $102.28 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $102.28
- Weighted AVG sell price:
- $102.28
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.